BASILE, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 169
EU - Europa 87
AS - Asia 28
Continente sconosciuto - Info sul continente non disponibili 1
Totale 285
Nazione #
US - Stati Uniti d'America 169
SE - Svezia 49
IT - Italia 20
CN - Cina 15
IN - India 10
DE - Germania 8
IE - Irlanda 5
HK - Hong Kong 3
FI - Finlandia 2
BE - Belgio 1
EU - Europa 1
GB - Regno Unito 1
GR - Grecia 1
Totale 285
Città #
New York 35
Ashburn 27
Shanghai 15
Lawrence 11
Princeton 11
Milan 8
Pune 8
Dublin 5
Rome 5
Hanover 3
Seattle 3
Turin 3
Washington 3
Cancello e Arnone 2
Detroit 2
Helsinki 2
Hong Kong 2
Hyderabad 2
Silver Spring 2
Athens 1
Borås 1
Brussels 1
Gaithersburg 1
Los Angeles 1
Manchester 1
Mountain View 1
Redwood City 1
San Antonio 1
Temecula 1
Vaprio d'Adda 1
Totale 160
Nome #
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 24
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 23
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 22
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 20
A global approach to improving penile cancer care 17
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 16
Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma 16
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 16
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 16
Cytoreductive Nephrectomy in Metastatic Patients with Signs or Symptoms: Implications for Renal Cell Carcinoma Guidelines 15
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 14
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 14
Differential Prognostic Value of Extrarenal Involvement in Patients With Non-Metastatic Renal Cell Cancer 12
"Case of the month from San Raffaele Hospital, Milan, Italy: paraneoplastic presentation of small renal masses" 12
Risks and benefits of partial nephrectomy performed with limited or with zero ischaemia time 12
Pancreatic metastases after surgery for renal cell carcinoma: survival and pathways of progression 12
The Learning Curve for Radical Nephrectomy for Kidney Cancer: Implications for Surgical Training 11
Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study 11
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 11
Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial 8
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 8
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 4
The Role of 99mTc-Sestamibi Single-photon Emission Computed Tomography/Computed Tomography in the Diagnostic Pathway for Renal Masses: A Systematic Review and Meta-analysis 4
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 1
null 1
Totale 320
Categoria #
all - tutte 3.490
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.490


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 3 1 0 0 0 0 0
2021/202224 0 5 0 6 2 0 1 0 1 0 0 9
2022/2023100 27 18 3 7 4 12 8 11 2 0 4 4
2023/2024192 12 20 22 19 15 47 1 40 5 9 2 0
Totale 320